Literature DB >> 17035508

Transcatheter closure of perimembranous ventricular septal defect: is the risk of heart block too high a price?

Ian D Sullivan.   

Abstract

The late development of heart block in paediatric patients following device closure of a perimembranous ventricular septal defect may be a cause for concern.

Entities:  

Mesh:

Year:  2006        PMID: 17035508      PMCID: PMC1861427          DOI: 10.1136/hrt.2006.103671

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

Review 1.  Morphology of perimembranous ventricular septal defects: implications for transcatheter device closure.

Authors:  Siew Yen Ho; Karen P McCarthy; Micheal L Rigby
Journal:  J Interv Cardiol       Date:  2004-04       Impact factor: 2.279

2.  Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study.

Authors:  J Masura; W Gao; P Gavora; K Sun; A Q Zhou; S Jiang; L Ting-Liang; Y Wang
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Perforation of the right aortic valve cusp: complication of ventricular septal defect closure with a modified Rashkind umbrella.

Authors:  M Vogel; M L Rigby; D Shore
Journal:  Pediatr Cardiol       Date:  1996 Nov-Dec       Impact factor: 1.655

4.  Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects.

Authors:  M Szkutnik; S A Qureshi; J Kusa; E Rosenthal; J Bialkowski
Journal:  Heart       Date:  2006-09-15       Impact factor: 5.994

5.  Transcatheter closure of congenital ventricular septal defects: experience with various devices.

Authors:  Ramesh Arora; Vijay Trehan; Ashish Kumar; G S Kalra; Madhuri Nigam
Journal:  J Interv Cardiol       Date:  2003-02       Impact factor: 2.279

6.  Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect.

Authors:  William C L Yip; Frank Zimmerman; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2005-11       Impact factor: 2.692

7.  Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience.

Authors:  Ziyad M Hijazi; Fakhri Hakim; A Abu Haweleh; Awni Madani; Walid Tarawna; Aktham Hiari; Qi-Ling Cao
Journal:  Catheter Cardiovasc Interv       Date:  2002-08       Impact factor: 2.692

8.  Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children.

Authors:  B D Thanopoulos; G S Tsaousis; E Karanasios; N G Eleftherakis; C Paphitis
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.

Authors:  John L Bass; G S Kalra; Ramesh Arora; Jozef Masura; Pavlo Gavora; Basil D Thanopoulos; William Torres; Horst Sievert; Mario Carminati; Gunther Fischer; Peter Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2003-02       Impact factor: 2.692

10.  Primary transcatheter umbrella closure of perimembranous ventricular septal defect.

Authors:  M L Rigby; A N Redington
Journal:  Br Heart J       Date:  1994-10
View more
  13 in total

1.  Perimembranous ventricular septal defect with aneurysm: two options for transcatheter closure.

Authors:  Chang Bian; Ji Ma; Jian'an Wang; Geng Xu; Jun Jiang; Shuyuan Yao; Yuehuai Liu
Journal:  Tex Heart Inst J       Date:  2011

2.  Transcatheter closure of perimembranous ventricular septal defect.

Authors:  Anita Dumitrescu; Geoffrey K Lane; James L Wilkinson; T H Goh; Daniel J Penny; Andrew M Davis
Journal:  Heart       Date:  2007-07       Impact factor: 5.994

3.  Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes.

Authors:  Jian Yang; Lifang Yang; Yi Wan; Jian Zuo; Jun Zhang; Wensheng Chen; Jun Li; Lijun Sun; Shiqiang Yu; Jincheng Liu; Tao Chen; Weixun Duan; Lize Xiong; Dinghua Yi
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

4.  Efficacy and Safety of Using Amplatzer Ductal Occluder for Transcatheter Closure of Perimembranous Ventricular Septal Defect in Pediatrics.

Authors:  Mehdi Ghaderian; Mahmood Merajie; Hodjjat Mortezaeian; Moghadam Aarabi; Yoosef Mohammad; Akbar Shah Mohammadi
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

5.  Cardiac resynchronization therapy for heart failure induced by left bundle branch block after transcatheter closure of ventricular septal defect.

Authors:  Rong-Zeng Du; Jun Qian; Jun Wu; Yi Liang; Guang-Hua Chen; Tao Sun; Ye Zhou; Yang Zhao; Jin-Chuan Yan
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

Review 6.  Recent advances in pediatric interventional cardiology.

Authors:  Seong-Ho Kim
Journal:  Korean J Pediatr       Date:  2017-08-14

Review 7.  Therapeutic Utilities of Pediatric Cardiac Catheterization.

Authors:  Giannis A Moustafa; Argyrios Kolokythas; Konstantinos Charitakis; Dimitrios V Avgerinos
Journal:  Curr Cardiol Rev       Date:  2016

8.  Postprocedural Outcomes and Risk Factors for Arrhythmias Following Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect: A Single-center Retrospective Study.

Authors:  Li-Jian Zhao; Bo Han; Jian-Jun Zhang; Ying-Chun Yi; Dian-Dong Jiang; Jian-Li Lyu
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

9.  Comparisons of perventricular device closure, conventional surgical repair, and transcatheter device closure in patients with perimembranous ventricular septal defects: a network meta-analysis.

Authors:  Dongxu Li; Xu Zhou; Mengsi Li; Qi An
Journal:  BMC Surg       Date:  2020-05-26       Impact factor: 2.102

10.  Percutaneous closure of perimembranous ventricular septal defect using patent ductus arteriosus occluders.

Authors:  Hieu Lan Nguyen; Quang Tan Phan; Dung Duc Doan; Linh Huynh Dinh; Hieu Ba Tran; Saima Sharmin; Julian Johny Thottian; Hoyoun Won; Wang Soo Lee; Seung Yong Shin; Truong Quang Nguyen; Sang Wook Kim
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.